Today: 29 April 2026
Nikkei 225 Ripped 3% as TOPIX Hit a Record—But Traders Keep Staring at 157
5 January 2026
1 min read

Nikkei 225 Ripped 3% as TOPIX Hit a Record—But Traders Keep Staring at 157

Tokyo — January 5, 2026 — 2:04 a.m. ET

  • Nikkei 225: 51,865.00 (+3.03%), day high 52,050
  • TOPIX: 3,477.52 (+2.01%), day high 3,486.00
  • USD/JPY: 157.295 high 

Nikkei ripped higher.
The Nikkei 225 closed up 3.03% at 51,865 in the Tokyo stock market’s first session of 2026, and TOPIX finished at 3,477.52, up 2.01% after touching 3,486 intraday. 

Risk-on hit Tokyo.
Traders chased chips and exporters as the dollar pushed to 157.295 yen and BOJ chief Kazuo Ueda talked about more rate hikes, while Venezuela headlines barely slowed the bid. 

Chips did the hauling.
Advantest jumped 6.37% and Tokyo Electron climbed about 6%, tracking a 4% surge in the U.S. semiconductor index on Friday and dragging index points with them. 

Exporters got the tailwind.
The cash Nikkei traded between 51,140 and 52,050 before it settled just under that 52,000 handle, and the weak-yen tape kept buyers leaning forward into the close. 

Rates stayed noisy.
Ueda told Japan’s bankers the BOJ keeps raising interest rates if growth and inflation track its forecasts, and that message turns the yen into the day’s real kill-switch for equities. 

Data gave cover.
A read on December factory activity showed the slump stabilized after five straight months of deterioration, and macro desks treated it like permission to add Japan exposure fast. 

TOPIX kept flexing breadth.
The broad gauge closed at 3,477.52 and tagged 3,486 at the high, so today’s move spread beyond a handful of Nikkei megacaps. 

Yeah, but risk stays.
A faster BOJ path plus any yen squeeze hits exporters hard, and geopolitics stays live after Washington captured Venezuela’s Nicolás Maduro over the weekend. 

Derivatives flashed a tell.
CME Nikkei 225 yen futures open interest slid to 92,826 contracts as of Sunday’s close, so positioning looked lighter than the price action in cash. 

Next catalyst: U.S. jobs.
Traders get ISM data early-week and nonfarm payrolls on Friday, then the BOJ’s Jan. 22–23 meeting and outlook report. 

Stock Market Today

  • Sensex Rallies 609 Points as Nifty Nears 24,200 on Strong Earnings and Geopolitical Hope
    April 29, 2026, 9:39 AM EDT. Indian benchmark indices rebounded Wednesday with the BSE Sensex rising 609 points (0.79%) to 77,496.36 and the NSE Nifty climbing 182 points (0.76%) to 24,177.65. Gains were broad-based, led by FMCG, auto, and telecom stocks. Maruti Suzuki surged nearly 3% following a record annual net profit, lifted by highest-ever sales and GST rate cuts. Positive earnings reports and easing geopolitical tensions fueled investor sentiment despite elevated crude oil prices which rose 2.85% to $114.4 a barrel. Asian markets also closed higher, reflecting a global mood shift. However, European and U.S. markets remained subdued. Analysts noted improved corporate performance and hopes of reduced global conflicts helped offset macroeconomic concerns and contributed to today's rebound.

Latest article

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

Biogen Cuts 2026 Profit Forecast After Q1 Beat as Leqembi Sales Surge

29 April 2026
Biogen lowered its 2026 adjusted earnings forecast to $14.25–$15.25 per share, citing research and development charges from recent acquisitions. First-quarter revenue rose 2% to $2.48 billion, with adjusted earnings of $3.57 per share, beating analyst estimates. Leqembi sales climbed 74% to $168 million globally.
Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
SoFi stock jumps into 2026 as Jan. 30 earnings date lands on calendar — what to watch next
Previous Story

SoFi stock jumps into 2026 as Jan. 30 earnings date lands on calendar — what to watch next

Silver price jumps on Maduro capture as SLV comes into focus ahead of U.S. jobs report
Next Story

Silver price jumps on Maduro capture as SLV comes into focus ahead of U.S. jobs report

Go toTop